What proportion of embryos should be considered for transfer following a mosaic diagnosis? A study of 115 clinics from a central diagnostic laboratory.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 01 11 2021
accepted: 02 12 2022
pmc-release: 01 03 2024
pubmed: 29 1 2023
medline: 25 3 2023
entrez: 28 1 2023
Statut: ppublish

Résumé

The aim of this study is to identify what proportion of mosaic embryo diagnoses should be considered for transfer, and thereby assess the impact on patient cases. We categorised mosaic embryos into 3 groups; high, medium and low priority for transfer based on the percentage of biopsy sample being aneuploid and the chromosomes involved. The categories were applied to those patients that had no euploid embryo diagnoses but 1 or more mosaic embryos identified as mosaic available after PGT-A. In total, 6614 PGT-A cases from 115 clinics and a single diagnostic laboratory were reviewed. Further, 1384 [20.9%] cases only had aneuploid embryos, 4538 [68.6%] cases had one or more euploid embryos and 692 [10.5%] cases had no euploid and one or more mosaic embryo. The mosaic embryos in the no euploid, one or more mosaic group, when reviewed using priorities, resulted in: 111 [1.7%] of cases having at least one high priority mosaic available. 184 [2.8%] of cases having no high priority but at least one medium priority mosaic available. 397 [6.0%] of cases only having low priority mosaic embryos available. Based on this data, embryos identified as mosaic will only be considered for transfer in the first instance for around 4.5% (when taking high and medium priority and excluding low priority cases) of all PGT-A cases.

Identifiants

pubmed: 36708429
doi: 10.1007/s10815-022-02678-8
pii: 10.1007/s10815-022-02678-8
pmc: PMC10033805
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

653-664

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Fertil Steril. 2018 Apr;109(4):627-632
pubmed: 29605407
Mol Cytogenet. 2012 Apr 10;5:19
pubmed: 22490612
Mutat Res. 1997 Dec 12;396(1-2):129-40
pubmed: 9434864
Reprod Biol Endocrinol. 2018 Jan 26;16(1):6
pubmed: 29373974
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):626-31
pubmed: 26729872
PLoS Genet. 2015 Oct 22;11(10):e1005601
pubmed: 26491874
Fertil Steril. 2016 Nov;106(6):1414-1419.e5
pubmed: 27692437
Syst Biol Reprod Med. 2017 Jun;63(3):206-208
pubmed: 28306341
Fertil Steril. 2021 May;115(5):1212-1224
pubmed: 33685629
J Assist Reprod Genet. 2021 Nov;38(11):2849-2860
pubmed: 34472017
Eur J Med Genet. 2020 Feb;63(2):103741
pubmed: 31445143
J Clin Med. 2020 Jun 02;9(6):
pubmed: 32498291
Fertil Steril. 2018 May;109(5):857-865
pubmed: 29778385
Zygote. 2018 Jun;26(3):191-198
pubmed: 29798732
Hum Reprod. 2013 Aug;28(8):2298-307
pubmed: 23739221
Fertil Steril. 2018 Jan;109(1):77-83
pubmed: 29191449
Mol Hum Reprod. 2010 Dec;16(12):944-9
pubmed: 20643877
Fertil Steril. 2019 Feb;111(2):280-293
pubmed: 30691630
Nat Med. 2009 May;15(5):577-83
pubmed: 19396175
J Assist Reprod Genet. 2014 Nov;31(11):1501-9
pubmed: 25241130
Hum Reprod. 2002 Sep;17(9):2362-7
pubmed: 12202426
Fertil Steril. 2017 May;107(5):1085-1091
pubmed: 28390692
Trends Genet. 2017 Jul;33(7):448-463
pubmed: 28457629
Am J Hum Genet. 2020 Apr 2;106(4):525-534
pubmed: 32220293
Reprod Biomed Online. 2019 Aug;39 Suppl 1:e1-e4
pubmed: 31421710
J Assist Reprod Genet. 2019 Jan;36(1):165-172
pubmed: 30246223
Mol Hum Reprod. 2020 Apr 24;26(4):269-276
pubmed: 32011698
Biol Reprod. 1994 Sep;51(3):373-9
pubmed: 7803609
Hum Reprod. 1993 Dec;8(12):2185-91
pubmed: 8150922
Fertil Steril. 2017 May;107(5):1083-1084
pubmed: 28433365
Hum Reprod. 2005 Mar;20(3):672-82
pubmed: 15689349
Hum Genet. 2017 Jul;136(7):805-819
pubmed: 28393271
N Engl J Med. 2015 Nov 19;373(21):2089-90
pubmed: 26581010
Mol Hum Reprod. 2018 Dec 1;24(12):593-601
pubmed: 30371814
Hum Mol Genet. 1993 Aug;2(8):1183-5
pubmed: 8401499
J Assist Reprod Genet. 2020 Mar;37(3):559-571
pubmed: 32112203
Reprod Biomed Online. 2018 Apr;36(4):442-449
pubmed: 29433970
Hum Genet. 1997 Jun;99(6):755-60
pubmed: 9187668
Hum Reprod. 2000 Aug;15(8):1781-6
pubmed: 10920103
Am J Hum Genet. 2021 Dec 2;108(12):2238-2247
pubmed: 34798051
Hum Reprod. 2018 Jul 1;33(7):1342-1354
pubmed: 29796631
Reprod Biomed Online. 2018 Jul;37(1):122
pubmed: 29754985
Reprod Biomed Online. 2018 Jul;37(1):120-121
pubmed: 29752003
Fertil Steril. 2017 May;107(5):1122-1129
pubmed: 28433371
Hum Reprod. 2020 Mar 27;35(3):727-733
pubmed: 32155260
Fertil Steril. 2017 Jul;108(1):62-71.e8
pubmed: 28579407
J Assist Reprod Genet. 2019 Jan;36(1):153-157
pubmed: 30362056

Auteurs

Kathryn D Sanders (KD)

School of Biosciences, University of Kent, Canterbury, CT2 7NJ, UK. kathryn.d.sanders@hotmail.com.

Darren K Griffin (DK)

School of Biosciences, University of Kent, Canterbury, CT2 7NJ, UK.

Henry J Martell (HJ)

School of Biosciences, University of Kent, Canterbury, CT2 7NJ, UK.

Joshua Blazek (J)

CooperGenomics, Houston, TX, USA.

Michael Large (M)

CooperGenomics, Houston, TX, USA.

Tony Gordon (T)

CooperGenomics, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH